InvestorsHub Logo
Followers 92
Posts 1193
Boards Moderated 0
Alias Born 09/10/2017

Re: Umibe5690 post# 373295

Thursday, 04/29/2021 5:16:02 AM

Thursday, April 29, 2021 5:16:02 AM

Post# of 730516
Thank you for clarifying, and for sharing Umibe. Everything that we know about DCVax, from the early trials, information arm patients, anecdotal patients, and blinded interim data, all suggest that DCVax will be a huge advance in the treatment for Glioblastoma, (and likely other cancers) and for this reason, there will be a path for approval. I also believe that the data will be welcomed by the medical community, GBM patients and their advocates, and there will be great demand. Top-tier journals, however, may not be so welcoming of the new endpoints, especially if the original endpoints didn’t reach statistical significance, so I will stick with my ASCO theory . . . for at least five more weeks.

I’m very sorry to read this about your wife. GBM is truly a horrible disease, and I also saw first hand how devastating it can be, and the lengths people will go to keep their loved ones alive. My grandfather also passed less than a year after his diagnosis. He didn’t want to try the Optune device because, at the time, it wasn’t covered by Medicare, and it cost $20k per month. My grandmother, however, was willing to spend their entire life savings to try ANYTHING to keep him alive. He hated the helmet, said it burned his head, and he blamed IT for his dizziness, nausea and seizures, and I think he wore it as little as possible in an attempt to speed up the inevitable.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News